Ambev S.A. filings document the reporting cycle of a Brazilian foreign private issuer with NYSE ADRs and B3-listed common shares. Form 20-F reports cover audited financial statements and annual business disclosure, while Form 6-K submissions furnish interim consolidated financial statements, quarterly operating results and current reports under Exchange Act rules for foreign issuers.
The filing record also covers beverage segment performance in Brazil Beer, Brazil NAB, Latin America South, Central America and the Caribbean, and Canada; capital allocation through interest on capital; treasury share activity; management and related-person securities transactions under Brazilian CVM rules; shareholder-meeting voting maps; board resolutions; committee matters; compensation; and other governance disclosures.
Ambev S.A. approved an IOC July 2026 distribution to shareholders, to be paid by December 31, 2026. The shareholding position on September 21, 2026 at B3 and September 23, 2026 at the NYSE will determine entitlement, and shares and ADRs will trade ex-IOC from September 22, 2026.
The standard withholding tax rate is 17.5%, subject to exemptions and international tax treaties. Non-resident holders seeking treaty benefits must submit documentation to the Investor Relations department by September 25, 2026. Credits will be deposited via Banco Bradesco or custodians, and the exact payment date will be set in a future board meeting.
Ambev S.A., a foreign private issuer, reports that its Board of Directors met on July 29, 2026 in São Paulo, with the minutes recorded in the company’s minute book and certified in extract form.
An exhibit attached to those minutes sets out the composition of the Board of Executive Officers effective September 1st, 2026, with a unified term of office running through December 31st, 2027. The extract is certified by Chairman Michel Dimitrios Doukeris and Secretary Guilherme Malik Parente, and the report is signed by Chief Financial and Investor Relations Officer and Investor Relations Officer Guilherme Fleury de Figueiredo Ferraz Parolari.
Ambev S.A. reported Q2 2026 results with organic total volumes up 1.4% and net revenue up 6.1% year over year. Normalized EBITDA grew 8.9% organically to R$ 6,376.7 million, expanding margin by 80 bps to 31.6%. Normalized profit increased 23.3% to R$ 3,492.7 million, with normalized EPS at R$ 0.22, up 24.2%.
Growth was led by Brazil Beer and Central America & Caribbean, offsetting lower volumes in Brazil NAB, Latin America South and Canada. Operating cash flow rose 54.5% to R$ 4,711.4 million. Ambev returned about R$ 5.9 billion to shareholders year to date and remains in a net cash position of R$ 15,397.4 million. The board set October 6, 2026 for a R$ 1.9 billion Interest on Capital payment and approved a new ~R$ 1.1 billion IOC distribution, while maintaining full-year guidance for Brazil Beer Cash COGS/hl growth between 4.5% and 7.5%.
Ambev S.A. reported consolidated net income of R$7,360,243 for the six months ended June 30, 2026, compared with R$6,595,215 a year earlier, on net sales of R$42,613,399 versus R$42,587,572. Income from operations was R$10,802,646, while basic EPS reached R$0.4584.
Operating cash flow increased to R$7,872,320 from R$4,254,012. Cash and cash equivalents were R$16,610,779 and interest-bearing loans and borrowings totaled R$2,948,960, with total equity of R$88,893,165 and total assets of R$138,209,009 at June 30, 2026.
Ambev continued capital returns, buying back 171,482,300 shares for R$2,751 million under its program and approving interest on capital of R$0.0449 per share (aggregate R$694,639). The company also discloses Brazilian tax proceedings totaling R$113,194,633 classified as possible losses with no provisions.
Ambev S.A. reports management and related persons’ positions in its securities for the period from June 1 to 30, 2026, under Article 11 of CVM Instruction 44/2021. The board of directors group held 30,679,627 common shares and 468,040 common ADRs at both the beginning and end of the month. The management group held 3,298,338 common shares and 19,790 common ADRs, with balances unchanged over the period. The fiscal council group held 2,500 common shares, also unchanged during June 2026.
Ambev S.A. reports its own share transactions for June 2026 under Article 11 of CVM Instruction 44/2021. The company held 247,967,585 common shares in treasury at the beginning of the period and 310,869,798 common shares at the end. Activity included delivery of 97,787 restricted shares at R$16.43 per share and multiple purchases of 3,000,000 common shares on various days through Corretora Santander, with examples including R$16.4202 per share on June 1 and R$16.6634 per share on June 29. All ADR positions are shown as zero throughout.
AMBEV S.A. executive Derbli de Carvalho Joao Coelho Rua filed an initial ownership report showing his equity stake in the company. He directly holds 101,461 common shares. In addition, he has several stock option grants on common shares with exercise prices around $3.41–$4.15 expiring between 2026 and 2029.
The filing also lists multiple restricted share awards that each convert into common shares as they vest, subject to withholding taxes. Footnotes state that different restricted share blocks vest on dates including December 1, 2026, March 1, 2027, December 2, 2027, February 28, 2028, December 1, 2028, and February 16, 2029, outlining a multi‑year vesting schedule.
AMBEV S.A. officer Paulo Andre Zagman reported an open-market sale of 136,250 common shares on May 5, 2026 at an average price of $3.41 per share. After this transaction, he directly holds 230,535 common shares, which include shares represented by American Depositary Shares.
The reported U.S. dollar price reflects a conversion from Brazilian reais using a foreign exchange rate of BRL 4.92 per $1.00 as of the transaction date.